PTC Therapeutics | PTCT - Lucro Bruto Sobre Vendas

Preço das Ações
65.88
Mudança Diária
-1.12 -1.67%
Mensal
-6.76%
Anual
16.33%
Q1 Previsão
62.54




Lucro Bruto Sobre Vendas Alterar Data
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amgen USD 6.48B 307M 2025-09
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Cytokinetics USD 17.76M 15.82M 2025-12
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Incyte USD 1.39B 118.68M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Novartis USD 10.82B 695M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
TG Therapeutics USD 154.43M 20.81M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Xencor USD 21M 22.61M 2025-09